Tag: Robert Bucelli December 22, 2025 New ALS drug stabilizes decline with improved strength, mobility for someLong-term use of tofersen slows ALS disease progression in people with a genetic subtype, provides hope for treating other forms of ALS.News Release April 25, 2023 Drug for rare form of ALS, based in part on WashU research, approved by FDAWashington University neurologist led international trials of the drug, tofersen.News Release, Video September 21, 2022 Investigational drug for genetic form of ALS improves disease’s molecular signsExtended use of tofersen may help stabilize muscle strength, control.News Release July 16, 2018 New ALS therapy in clinical trialsDrug extends survival, reverses some neuromuscular damage in animals.News Release Posts navigation
